Evidence map›Paper›PMID 35041510›Full record

ArticleAntimicrobial agents and chemotherapy2022

Jose-Manuel Ortiz de la Rosa, Patrice Nordmann, Zhiyong Zong, Laurent Poirel

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 58% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Fosfomycin resistance mechanisms inFrontiers in cellular and infection microbiology · 2023
    Review
  3. Wildlife and Antibiotic Resistance.Frontiers in cellular and infection microbiology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 3 countries.

Jose-Manuel Ortiz de la RosaEmerging Antibiotic Resistance, Medical and Molecular Microbiology, Department of Medicine, University of Fribourggrid.8534.a, Fribourg, Switzerland.
Patrice NordmannEmerging Antibiotic Resistance, Medical and Molecular Microbiology, Department of Medicine, University of Fribourggrid.8534.a, Fribourg, Switzerland.ORCID 0000-0002-1343-1622
Zhiyong ZongCenter for Pathogen Research, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Laurent PoirelEmerging Antibiotic Resistance, Medical and Molecular Microbiology, Department of Medicine, University of Fribourggrid.8534.a, Fribourg, Switzerland.ORCID 0000-0001-5160-5286
University of Fribourg · CHSichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

FosfomycinAnti-Bacterial AgentsGammaproteobacteriaIntegronsMicrobial Sensitivity TestsPlasmidsPolymerase Chain ReactionAnti-Bacterial AgentsFosfomycinAliidiomarina shirensisFosCfosfomycingene cassetteintegron

Identifiers

PMID35041510
PMCPMC8923222
OpenAlexW4206591879

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.